OncoSil AGM CEO Presentation
Filed with ASX · · 39 pages · English
Sydney, Australia – 29 October 2019: OncoSil Medical Ltd (ASX: OSL) (OncoSil or the Company), a medical device company focused on localised treatments for patients with pancreatic and liver cancer, has released its CEO presentation for the Annual General Meeting of OncoSil shareholders to be held at 11:00am AEDT today. About OncoSil OncoSil Medical is a medical device company seeking to advance ra
In the deck
Story so far
Earlier from OncoSil Medical
- Receipt of $3.8M R&D Tax Incentive
- Appendix 4E and Full Year Statutory Accounts
- Response to ASX Price Query
- Update - CE Marking Application
- CE Marking Update
Later from OncoSil Medical
- Positive CE Mark Status Report
- CE Mark Update
- FDA Grants Breakthrough Device Designation
- Pause in Trading
- Clarification Statement
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical